2025
Brain Navi Biotechnology has officially entered the Spanish market, completing its first NaoTrac-assisted neurosurgeries in collaboration with Palex Healthcare.
Cottbus, Germany – The first surgeries with the neurosurgical navigation robot NaoTrac have now been successfully started at the Medizinische Universität Lausitz – Carl Thiem.
Brain Navi Biotechnology has officially received U.S. FDA 510(k) clearance for its neurosurgical robot NaoTrac, now classified as a "Stereotaxic Guiding Surgical Device."
Dr. Hao-Yu Chuang's team used NaoTrac for stereotactic brain surgeries, achieving high accuracy in tumor biopsies and ICH drainage. The results were recognized at AANS.
2025
Today’s neurosurgical navigation systems face critical limitations that continue to challenge surgeons and OR teams alike. From slow workflows to registration inaccuracies, these pain points can directly impact surgical precision and patient safety.
Cottbus, Germany – The first surgeries with the neurosurgical navigation robot NaoTrac have now been successfully started at the Medizinische Universität Lausitz – Carl Thiem.
We’re excited to share that Brain Navi will be exhibiting at several major international events in the second half of the year, including Medical Fair Asia Thailand, Medical Japan, EANS Vienna, and MEDICA Düsseldorf.
Brain Navi Biotechnology has officially received U.S. FDA 510(k) clearance for its neurosurgical robot NaoTrac, now classified as a "Stereotaxic Guiding Surgical Device."
Brain Navi Biotechnology has officially entered the Spanish market, completing its first NaoTrac-assisted neurosurgeries in collaboration with Palex Healthcare.
Dr. Hao-Yu Chuang's team used NaoTrac for stereotactic brain surgeries, achieving high accuracy in tumor biopsies and ICH drainage. The results were recognized at AANS.
In collaboration with Palex Healthcare, we introduce NaoTrac, the advanced neurosurgical navigation robot enhancing precision and safety. Join us in SENEC as we support innovation and excellence in Spanish neurosurgery.
Brain Navi Biotechnology has announced a strategic partnership with BenQ Medical Technology to introduce and commercialize the NaoTrac neurosurgical navigation robot in the Chinese market.
Brain Navi is joining AANS 2025 for the first time, bringing NaoTrac, our Surgical navigation robot, closer to the U.S. neurosurgery market.